DNA/GENE MICROARRAY MARKET ANALYSIS

DNA/Gene Microarray Market, By Type (Oligonucleotide DNA Microarrays, Complementary DNA Microarrays),By Application (Genomics, Proteomics, Agricultural Biology, Environment, Drug Research and Development, Cancer/oncology, Others (SNP Analysis, etc.)),By End User (Biopharmaceutical and Pharmaceutical Companies, Diagnostic Laboratories, Research Laboratories, Others (Academic Institutes, etc.)), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)

Global DNA/Gene Microarray Market– Drivers

Rising strategic initiatives taken by the market players: The key market players are focused on strategic initiatives, which, in turn, are expected to fuel market growth over the forecast period. For instance, in March 2021, Oxford BioDynamics Plc, a global biotechnology company, and Agilent Technologies, a provider of scientific solutions, announced that they had signed a supply and resale agreement for the manufacturing and sale of the new EpiSwitch Explorer Array Kit. EpiSwitch Explorer Array Kit is a microarray kit available for high-resolution 3D (3-dimensional) genome profiling and biomarker discovery.

Increasing prevalence of cancer: Increasing changes in lifestyles are considered a major cause of cancer. Thus, the increasing prevalence of cancer globally is expected to boost growth of the market over the forecast period, as arrays are used in diagnostics for various indications such as cancer and others. For instance, according to the data published by the American Cancer Society in 2021, cancer facts and figures in the U.S. reported the estimated number of cancer cases in the U.S. in 2021, which is provided below:

DNA/Gene Microarray Market Report Snapshots